These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14961567)

  • 1. Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors.
    Ghabreau L; Roux JP; Frappart PO; Mathevet P; Patricot LM; Mokni M; Korbi S; Wang ZQ; Tong WM; Frappart L
    Int J Cancer; 2004 Apr; 109(3):317-21. PubMed ID: 14961567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H
    Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase expression increases throughout the endometrial hyperplasia-cancer sequence.
    Canaani J; Ilan N; Back S; Gutman G; Vlodavsky I; Grisaru D
    Int J Gynaecol Obstet; 2008 May; 101(2):166-71. PubMed ID: 18221741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G; Xu X; Chu C; Acs P; Verma A
    Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP-1 activity in normal and cancerous human endometrium and its relationship with quantity of abasic sites (AP).
    Postawski K; Monist M; Keith G
    Ginekol Pol; 2011 Jan; 82(1):16-21. PubMed ID: 21469519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
    Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
    Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
    Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
    Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E-Cadherin expression vs. tumor cell proliferation paradox in endometrial cancer.
    González-Rodilla I; Aller L; Llorca J; Muñoz AB; Verna V; Estévez J; Schneider J
    Anticancer Res; 2013 Nov; 33(11):5091-5. PubMed ID: 24222154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the DNA global methylation status and progesterone receptor expression in normal endometrium, endometrioid adenocarcinoma and precursors.
    Ghabreau L; Roux JP; Niveleau A; Fontanière B; Mahe C; Mokni M; Frappart L
    Virchows Arch; 2004 Aug; 445(2):129-34. PubMed ID: 15221375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC; Meinel A; Handzel R; Einenkel J
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
    Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
    Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of immunohistochemical profile in assessing histological grade of endometrial cancer.
    Canlorbe G; Laas E; Bendifallah S; Daraï E; Ballester M
    Anticancer Res; 2013 May; 33(5):2191-8. PubMed ID: 23645775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of poly-ADP-ribose polymerase (PARP) in endometrial adenocarcinoma: Prognostic potential.
    Lawrence LM; Russell R; Denning CE; Zgheib NB; Salisbury T; Lirette ST; Valluri J; Claudio PP; Denning KL
    Pathol Res Pract; 2020 Jun; 216(6):152965. PubMed ID: 32360251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia.
    Brustmann H
    Int J Gynecol Pathol; 2005 Apr; 24(2):184-92. PubMed ID: 15782075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
    Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
    Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.